GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

Reuters India

28 May 2020 0 shares 1 views

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

Reuters India

Published 28 May 2020

GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.

Full Article

GSK to produce 1 billion doses of coronavirus vaccine booster next year

Khaleej Times 28 May 2020

'We believe that more than one vaccine will be needed to address this global pandemic'

GSK aims for one billion doses of booster as COVID-19 vaccine race heats up
Reuters India 28 May 2020
GSK aims for 1 billion doses with COVID vaccine booster plan
Reuters India 28 May 2020
GSK to produce 1bn doses of coronavirus vaccine booster
FT.com 28 May 2020
GSK to produce 1 bln doses of coronavirus vaccine booster in 2021
Reuters India 28 May 2020

More coverage

Dr. Moncef Slaoui, America’s Arab ‘Coronavirus Vaccine Czar’ – Profile

Facing criticism over his handling of the COVID-19 pandemic, US President Donald Trump has tapped one of the Arab American..

Eurasia Review 21 May 2020

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

You might like

Related news coverage

GSK to produce 1 billion doses of coronavirus vaccine booster next year

Advertisement

More coverage

Dr. Moncef Slaoui, America’s Arab ‘Coronavirus Vaccine Czar’ – Profile